Genesis Expanded Diarrhea Pathogen Panel
26 Pathogens with Genotypic Antibiotic Resistance
This is an integrated multiplex PCR-based test for the simultaneous detection of 26 of the most commonly diagnosed diarrhea pathogens in humans (14 bacterial species, including toxigenic C. difficile A/B, 9 viruses, and 3 parasites). This panel test is performed using the Applied Biosystems® OpenArray™ technology, which is ≥99% in both sensitivity and specificity for the above pathogen grouping.
This DPP panel has been shown to have a much higher (at least 4.4-fold) detection rate than conventional methods and has also been shown to improve clinical management, reduce or eliminate hospital stays, and lower healthcare costs significantly1. The turnaround time (TAT) for this test is 24 hours after the sample is received in our lab, and our staff reports the positive results to the referring practices immediately after completion. The samples are usually sent overnight via Federal Express by the patients in the provided pre-paid envelope, and hence the results are known in most instances within 24 hours to the physician and the patient. For the complete list of pathogens and genotypic antibiotic resistance markers tested, click here.
The broader impact of the Genesis Expanded Diarrhea Pathogen Panel (26 Pathogens with Genotypic Antibiotic Resistance)
Epidemiology and Public Health